Your new post is loading...
Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China.
Influenza in birds graphic from Russell Kightley Media
I keep saying, you gotta go green...and Medicago do, and have for H7N9.
Quicker than anyone else, evidently. Truly impressive for plant production technology!